Low ABCB1 and high OCT1 levels play a favorable role in the molecular response to imatinib in CML patients in the community clinical practice

Autor: da Cunha Vasconcelos, Flavia, Mauricio Scheiner, Marcos Antonio, Moellman-Coelho, Arthur, Mencalha, André Luiz, Renault, Ilana Zalcberg, Rumjanek, Vivian Mary, Maia, Raquel Ciuvalschi
Zdroj: In Leukemia Research December 2016 51:3-10
Databáze: ScienceDirect